# Chronic Myeloid Leukemia Treatments

{
  "id": "T11215",
  "title": "Chronic Myeloid Leukemia Treatments",
  "url": "/topics/T11215",
  "kind": "topic-directory",
  "aeo_cohort": "topic-directory",
  "provider": "openalex",
  "revision": "f6e0ffcb475b4e96",
  "catalogue_revision": "f050b5d4780b1289",
  "numeric_address": "36240765604768170",
  "address_version": "morton4x16-v1",
  "coordinates": [
    4,
    27,
    2720,
    11215
  ],
  "answer_status": "Directory metadata; local answer requires separate source review",
  "truth_status": "Subject descriptor, not a factual answer or a demonstrated knowledge gap"
}

This cluster of papers focuses on the efficacy and resistance of various tyrosine kinase inhibitors, such as Imatinib, Dasatinib, and Nilotinib, in the treatment of Chronic Myeloid Leukemia (CML). The papers discuss molecular mechanisms of resistance, mutation analysis, leukemia stem cells, treatment discontinuation, and long-term outcomes of different targeted therapies.

Directory metadata is not a factual answer or evidence of a global knowledge gap.

Source: https://openalex.org/T11215

No owner-reviewed local answer yet.